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Introduction: Carbapenems have been our trusted allies in the battle against multi-
drug resistant infections caused by Enterobacteriaceae. However, carbapenem 
resistant Enterobacteriaceae (CRE) have emerged rapidly over the past decade. 
Carbapenemase production is the commonest mechanism of resistance among CRE. 
The treatment of infections caused by CRE is a challenge because of the limited 
effective drug options. The current opinion is to revive the older antibiotics as 
treatment options against CRE. 
 
Aim: To characterize carbapenem resistant organisms causing urinary tract 
infections in hospitalized patients using phenotypic and molecular methods.   
 
Objectives:  
i To determine the prevalence of carbapenem resistant 
Enterobacteriaceae causing UTI among hospitalized patients. 
ii To detect the various carbapenem resistance mechanisms by performing 
the following tests: 
a. Phenotypic differentiation of carbapenemase and non-
carbapenemase mediated mechanisms by the Modified Hodge 
Test, CarbaNP test and SUPERCARBA CHROMagar. 
b. Molecular characterization of blaKPC, blaNDM, blaIMP, blaVIM and 
blaOXA48 like genes by multiplex-PCR.   
iii. To determine in-vitro activity of colistin, fosfomycin and 
nitrofurantoin against the isolates and screen resistant isolates for 
plasmid mediated resistance mechanisms. 
iv. To study the treatment outcomes of these infections 
 
Materials and methods: 
A total of 3833 consecutive urine specimens were included for calculation of 
prevalence of CRE UTI. And, 150 consecutive, non-repeat, specimens 
satisfying inclusion/exclusion criteria were included: E.coli (n=81) and 
Klebsiella spp (n=69) and characterized, based on gender, age, admitting 
department, method of sample collection, presence of co-morbidities or risk 
factors predisposing to UTI and treatment outcomes in patients. Klebsiella spp 
(n=69) were reclassified into K. pneumoniae (n=47) and Raoultella spp (n=22) 
using latest classification scheme. Further characterization of CRE was done 
using Multiplex PCR for presence of blaKPC, blaNDM, blaIMP , 
blaVIM and blaOXA48 like genes and using phenotypic tests MHT, CarbaNP 
and SUPERCARBA chromagar for carbapenemase production and comparison 
between them. 
Antimicrobial susceptibility testing using routinely tested drugs as well as older 
drugs of renewed interest. Susceptibilities to fosfomycin and nitrofurantoin 
were determined by MIC E-test. Colistin susceptibility was determined using 
micro broth dilution method (current gold standard). Screening of resistant 
isolates for plasmid mediated resistance mechanisms; Colistin- Screening of 
resistant isolates (n=14) using PolymyxinNP test and PCR for plasmid borne 
mobile colistin resistance gene mcr-1; Nitrofurantoin- Resistant or intermediate 
E.coli (n=36) for presence of plasmid borne oqxAB genes encoding efflux 
pump and Fosfomycin:- Isolate testing intermediate susceptible (n=1) for 
plasmid borne fosA3 gene  
Results: Prevalence of CRE UTI was 2.9% during the study period. The 150 
isolates were identified as 81 E.coli, 47 Klebsiella pneumoniae and 22 
Raoultella species. Carbapenemase encoding genes were detected in 108 
isolates. The commonest gene being blaNDM followed by blaOXA-48 like. 
Commonest gene in E.coli being blaNDM; in K.pneumoniae and Raoultella 
spp being blaOXA-48 like  In-vitro susceptibility rates to colistin, fosfomycin 
and nitrofurantoin, respectively, were 95%, 100% and 75% for E.coli and 89%, 
95% and 0% for Klebsiella pneumoniae; and 77%, 95% and 0% for Raoultella 
species. Colistin resistant isolates tested positive by PolymyxinNP but 
molecular screening for plasmid-borne mobile colistin resistance gene (mcr-1) 
was negative. Plasmid borne resistance genes oqxAB were absent in 
nitrofurantoin resistant E.coli.  
Discussion and conclusion: The characterization of resistance mechanisms in CRE 
plays a vital role in hospital infection control as the carbapenemase producing genes 
are borne on plasmids and tend to spread rapidly in a hospital setting. SUPERCARBA 
CHROMagar emerged as sensitive test for carbapenemase detection including OXA- 
48 like producers. We found considerable in vitro activity of colistin and fosfomycin 
against CRE and of nitrofurantoin against carbapenem resistant E.coli. In a situation 
where most newer drugs have fallen prey to bacterial resistance mechanisms, revival 
of older drugs for treatment of CRE UTI may be worthwhile. Absence of plasmid 
borne resistance genes in organisms resistant to older drugs is encouraging. 
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